Does DABIGATRAN ETEXILATE Cause Transient ischaemic attack? 471 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 471 reports of Transient ischaemic attack have been filed in association with DABIGATRAN ETEXILATE (dabigatran etexilate). This represents 1.3% of all adverse event reports for DABIGATRAN ETEXILATE.
471
Reports of Transient ischaemic attack with DABIGATRAN ETEXILATE
1.3%
of all DABIGATRAN ETEXILATE reports
7
Deaths
232
Hospitalizations
How Dangerous Is Transient ischaemic attack From DABIGATRAN ETEXILATE?
Of the 471 reports, 7 (1.5%) resulted in death, 232 (49.3%) required hospitalization, and 26 (5.5%) were considered life-threatening.
Is Transient ischaemic attack Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DABIGATRAN ETEXILATE. However, 471 reports have been filed with the FAERS database.
What Other Side Effects Does DABIGATRAN ETEXILATE Cause?
Gastrointestinal haemorrhage (4,081)
Cerebrovascular accident (2,175)
Fall (1,786)
Ischaemic stroke (1,581)
Anaemia (1,412)
Haemorrhage (1,324)
Death (1,025)
Rectal haemorrhage (964)
Cerebral haemorrhage (946)
Upper gastrointestinal haemorrhage (861)
What Other Drugs Cause Transient ischaemic attack?
APIXABAN (1,157)
RIVAROXABAN (820)
LENALIDOMIDE (655)
ADALIMUMAB (604)
ASPIRIN (587)
ROSIGLITAZONE (585)
NAPROXEN (521)
LEVOTHYROXINE (517)
CLOPIDOGREL BISULFATE (454)
SIMVASTATIN (415)
Which DABIGATRAN ETEXILATE Alternatives Have Lower Transient ischaemic attack Risk?
DABIGATRAN ETEXILATE vs DABRAFENIB
DABIGATRAN ETEXILATE vs DABRAFENIB\TRAMETINIB
DABIGATRAN ETEXILATE vs DACARBAZINE
DABIGATRAN ETEXILATE vs DACLATASVIR
DABIGATRAN ETEXILATE vs DACLIZUMAB